Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BMEA |
---|---|---|
09:32 ET | 24138 | 5.5501 |
09:34 ET | 7357 | 5.45 |
09:36 ET | 31159 | 5.42 |
09:38 ET | 7492 | 5.49 |
09:39 ET | 13858 | 5.51 |
09:41 ET | 34348 | 5.48 |
09:43 ET | 7573 | 5.4602 |
09:45 ET | 16226 | 5.325 |
09:48 ET | 42582 | 5.1699 |
09:50 ET | 52809 | 5.05 |
09:52 ET | 21653 | 5.08 |
09:54 ET | 21860 | 5.02 |
09:56 ET | 21342 | 5.09 |
09:57 ET | 12726 | 5.05 |
09:59 ET | 102201 | 4.79 |
10:01 ET | 29428 | 4.78 |
10:03 ET | 45663 | 4.79 |
10:06 ET | 37545 | 4.73 |
10:08 ET | 19366 | 4.77 |
10:10 ET | 31315 | 4.93 |
10:12 ET | 15156 | 4.9499 |
10:14 ET | 13498 | 4.945 |
10:15 ET | 24427 | 4.9 |
10:17 ET | 7808 | 4.93 |
10:19 ET | 10161 | 4.8701 |
10:21 ET | 6418 | 4.8247 |
10:24 ET | 8565 | 4.86 |
10:26 ET | 6354 | 4.88 |
10:28 ET | 13874 | 4.845 |
10:30 ET | 13734 | 4.83 |
10:32 ET | 22262 | 4.82 |
10:33 ET | 5621 | 4.85 |
10:35 ET | 20755 | 4.805 |
10:37 ET | 16613 | 4.86 |
10:39 ET | 12799 | 4.86 |
10:42 ET | 1592 | 4.835 |
10:44 ET | 3955 | 4.815 |
10:46 ET | 10889 | 4.845 |
10:48 ET | 2140 | 4.85 |
10:50 ET | 8858 | 4.81 |
10:51 ET | 6389 | 4.8001 |
10:53 ET | 4200 | 4.82 |
10:55 ET | 1591 | 4.8168 |
10:57 ET | 13447 | 4.85 |
11:00 ET | 7067 | 4.81 |
11:02 ET | 3695 | 4.81 |
11:04 ET | 3100 | 4.825 |
11:06 ET | 10055 | 4.83 |
11:08 ET | 13089 | 4.9001 |
11:09 ET | 5239 | 4.9 |
11:11 ET | 8188 | 4.9199 |
11:13 ET | 5506 | 4.88 |
11:15 ET | 2300 | 4.8775 |
11:18 ET | 2409 | 4.875 |
11:20 ET | 7745 | 4.84 |
11:22 ET | 2000 | 4.85 |
11:24 ET | 2958 | 4.87 |
11:26 ET | 6201 | 4.86 |
11:27 ET | 7401 | 4.89 |
11:29 ET | 11139 | 4.94 |
11:31 ET | 6889 | 4.98 |
11:33 ET | 5473 | 4.985 |
11:36 ET | 2358 | 4.95 |
11:38 ET | 11570 | 4.93 |
11:40 ET | 755 | 4.925 |
11:42 ET | 6695 | 4.92 |
11:44 ET | 15312 | 4.88 |
11:45 ET | 3700 | 4.9 |
11:47 ET | 7451 | 4.875 |
11:49 ET | 300 | 4.87 |
11:51 ET | 5295 | 4.8575 |
11:54 ET | 844 | 4.8699 |
11:56 ET | 5389 | 4.84 |
11:58 ET | 1798 | 4.84 |
12:00 ET | 11046 | 4.9 |
12:02 ET | 14817 | 4.96 |
12:03 ET | 12799 | 4.97 |
12:05 ET | 2300 | 4.99 |
12:07 ET | 12236 | 4.94 |
12:09 ET | 4040 | 4.94 |
12:12 ET | 3724 | 4.94 |
12:14 ET | 170 | 4.9403 |
12:16 ET | 4026 | 4.9218 |
12:18 ET | 3867 | 4.925 |
12:20 ET | 8466 | 4.9799 |
12:21 ET | 5000 | 4.952 |
12:23 ET | 4827 | 4.945 |
12:25 ET | 1100 | 4.97 |
12:27 ET | 4861 | 4.965 |
12:30 ET | 4310 | 5 |
12:32 ET | 1782 | 4.985 |
12:34 ET | 3800 | 4.995 |
12:36 ET | 1500 | 5 |
12:38 ET | 2555 | 4.99 |
12:39 ET | 3456 | 4.99 |
12:41 ET | 3552 | 5.005 |
12:43 ET | 11727 | 5.04 |
12:45 ET | 6410 | 5.0031 |
12:48 ET | 7071 | 5.035 |
12:50 ET | 1188 | 5.04 |
12:52 ET | 3100 | 5.07 |
12:54 ET | 2448 | 5.075 |
12:56 ET | 2579 | 5.09 |
12:57 ET | 5835 | 5.0875 |
12:59 ET | 1086 | 5.1 |
01:01 ET | 4583 | 5.1 |
01:03 ET | 2000 | 5.1 |
01:06 ET | 2300 | 5.12 |
01:08 ET | 4049 | 5.1369 |
01:10 ET | 3286 | 5.15 |
01:12 ET | 2200 | 5.1414 |
01:14 ET | 5849 | 5.17 |
01:15 ET | 11616 | 5.15 |
01:17 ET | 3731 | 5.15 |
01:19 ET | 200 | 5.145 |
01:21 ET | 7915 | 5.16 |
01:24 ET | 2383 | 5.145 |
01:26 ET | 8315 | 5.18 |
01:28 ET | 5442 | 5.19 |
01:30 ET | 4389 | 5.185 |
01:32 ET | 4028 | 5.155 |
01:33 ET | 800 | 5.1512 |
01:35 ET | 2318 | 5.155 |
01:37 ET | 3485 | 5.135 |
01:39 ET | 2800 | 5.12 |
01:42 ET | 2688 | 5.1299 |
01:44 ET | 7577 | 5.1 |
01:46 ET | 7930 | 5.13 |
01:48 ET | 600 | 5.14 |
01:50 ET | 1337 | 5.155 |
01:51 ET | 802 | 5.155 |
01:53 ET | 2270 | 5.17 |
01:55 ET | 6467 | 5.155 |
01:57 ET | 2918 | 5.17 |
02:00 ET | 2664 | 5.17 |
02:02 ET | 9257 | 5.19 |
02:04 ET | 3900 | 5.195 |
02:06 ET | 3200 | 5.2 |
02:08 ET | 2900 | 5.23 |
02:09 ET | 2101 | 5.21 |
02:11 ET | 1148 | 5.22 |
02:13 ET | 5100 | 5.245 |
02:15 ET | 563 | 5.25 |
02:18 ET | 1815 | 5.245 |
02:20 ET | 4284 | 5.2 |
02:22 ET | 1150 | 5.18 |
02:24 ET | 2259 | 5.16 |
02:26 ET | 4115 | 5.16 |
02:29 ET | 2866 | 5.165 |
02:31 ET | 2641 | 5.175 |
02:33 ET | 1914 | 5.16 |
02:36 ET | 4035 | 5.16 |
02:38 ET | 698 | 5.155 |
02:40 ET | 10500 | 5.195 |
02:42 ET | 6768 | 5.19 |
02:44 ET | 2744 | 5.19 |
02:45 ET | 200 | 5.185 |
02:47 ET | 3393 | 5.17 |
02:49 ET | 7014 | 5.19 |
02:51 ET | 300 | 5.195 |
02:54 ET | 3500 | 5.21 |
02:56 ET | 853 | 5.215 |
02:58 ET | 8797 | 5.235 |
03:00 ET | 3945 | 5.21 |
03:02 ET | 2977 | 5.205 |
03:03 ET | 4215 | 5.215 |
03:05 ET | 2052 | 5.205 |
03:07 ET | 7642 | 5.17 |
03:09 ET | 1351 | 5.16 |
03:12 ET | 12598 | 5.145 |
03:14 ET | 1956 | 5.14 |
03:16 ET | 1689 | 5.14 |
03:18 ET | 5986 | 5.145 |
03:20 ET | 5932 | 5.145 |
03:21 ET | 3400 | 5.145 |
03:23 ET | 1000 | 5.145 |
03:25 ET | 20779 | 5.23 |
03:27 ET | 11099 | 5.205 |
03:30 ET | 2949 | 5.19 |
03:32 ET | 6845 | 5.195 |
03:34 ET | 9193 | 5.195 |
03:36 ET | 836 | 5.195 |
03:38 ET | 3612 | 5.19 |
03:39 ET | 11687 | 5.172 |
03:41 ET | 6296 | 5.161 |
03:43 ET | 7776 | 5.155 |
03:45 ET | 22514 | 5.16 |
03:48 ET | 10318 | 5.12 |
03:50 ET | 17643 | 5.13 |
03:52 ET | 5057 | 5.125 |
03:54 ET | 22159 | 5.15 |
03:56 ET | 18570 | 5.105 |
03:57 ET | 26042 | 5.08 |
03:59 ET | 38493 | 5.09 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Biomea Fusion Inc | 202.7M | -1.4x | --- |
Ventyx Biosciences Inc | 203.0M | -0.8x | --- |
Rani Therapeutics Holdings Inc | 203.2M | -3.0x | --- |
Design Therapeutics Inc | 209.6M | -3.7x | --- |
Prelude Therapeutics Inc | 214.2M | -2.1x | --- |
Greenwich Lifesciences Inc | 190.1M | -24.3x | --- |
Biomea Fusion, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of oral covalent small molecules to treat patients with metabolic diseases and genetically defined cancers. A covalent small molecule is a synthetic compound that forms a permanent bond to its target protein. The Company is utilizing its proprietary FUSION System to discover, design and develop a pipeline of covalent-binding small molecule medicines designed to maximize clinical benefit for patients. Its lead product candidate, BMF-219, is designed to be an oral, potent, and selective covalent inhibitor of menin, built from its FUSION System. It is developing BMF-219 for the treatment of menin regulated or dependent diseases, such as type 1 and type 2 diabetes as well as subtypes of liquid and solid tumors. Its second development candidate, BMF-500, a covalent inhibitor of activating mutations of the FMS-like tyrosine kinase 3 (FLT3).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $183.0M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 35.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-3.57 |
Book Value | $4.72 |
P/E Ratio | -1.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.